Richard B Warren

Richard B Warren

UNVERIFIED PROFILE

Are you Richard B Warren?   Register this Author

Register author
Richard B Warren

Richard B Warren

Publications by authors named "Richard B Warren"

Are you Richard B Warren?   Register this Author

79Publications

2127Reads

19Profile Views

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses.

Dermatol Ther (Heidelb) 2019 Nov 4. Epub 2019 Nov 4.

Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13555-019-00337-yDOI Listing
November 2019

Author Correction: Genotypic variability-based genome-wide association study identifies non-additive loci HLA-C and IL12B for psoriasis.

J Hum Genet 2019 Aug;64(8):831

Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, University of Manchester, Manchester, M6 8HD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s10038-019-0605-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760575PMC
August 2019

The Potential Benefits of Certolizumab Pegol in Patients with Concurrent Psoriatic Arthritis and Chronic Plaque Psoriasis: A Case Series and Review of the Literature.

Dermatol Ther (Heidelb) 2019 Jun 16;9(2):373-381. Epub 2019 Mar 16.

The Dermatology Centre, Salford Royal NHS Foundations Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13555-019-0290-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522617PMC
June 2019

Brodalumab in psoriasis: evidence to date and clinical potential.

Drugs Context 2019 17;8:212570. Epub 2019 Apr 17.

The Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester Biomedical Research Centre, Manchester, M6 8HD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7573/dic.212570DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474429PMC
April 2019

A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis.

J Invest Dermatol 2019 01 17;139(1):100-107. Epub 2018 Jul 17.

Centre for Translational Bioinformatics, William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2018.04.041DOI Listing
January 2019

Defining the Therapeutic Range for Adalimumab and Predicting Response in Psoriasis: A Multicenter Prospective Observational Cohort Study.

J Invest Dermatol 2019 01 18;139(1):115-123. Epub 2018 Aug 18.

St John's Institute of Dermatology, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, UK; St. John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2018.07.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300405PMC
January 2019

Ustekinumab for the treatment of psoriasis: an evidence update.

Semin Cutan Med Surg 2018 Sep;37(3):143-147

Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
https://scmsjournal.com/article/buy_now/?id=785
Publisher Site
http://dx.doi.org/10.12788/j.sder.2018.040DOI Listing
September 2018

Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

J Invest Dermatol 2018 04 6;138(4):775-784. Epub 2017 Dec 6.

Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences and NIHR Manchester Biomedical Research Centre, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2017.09.044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869053PMC
April 2018

Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

J Invest Dermatol 2018 03 17;138(3):534-541. Epub 2017 Oct 17.

Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2017.10.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832757PMC
March 2018

Genotypic variability-based genome-wide association study identifies non-additive loci HLA-C and IL12B for psoriasis.

J Hum Genet 2018 Mar 19;63(3):289-296. Epub 2017 Dec 19.

Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, University of Manchester, Manchester, M6 8HD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s10038-017-0350-6DOI Listing
March 2018

Impact of Disease Severity, Illness Beliefs, and Coping Strategies on Outcomes in Psoriatic Arthritis.

Arthritis Care Res (Hoboken) 2018 02 29;70(2):295-302. Epub 2017 Dec 29.

University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/acr.23330DOI Listing
February 2018

Guselkumab for psoriasis: a critical appraisal of Phase III studies.

Immunotherapy 2018 01 18;10(1):67-75. Epub 2017 Oct 18.

Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK, M13 9PT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2017-0106DOI Listing
January 2018

Re: Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis.

J Invest Dermatol 2017 12 31;137(12):2644-2646. Epub 2017 Aug 31.

St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust & King's College, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2017.07.848DOI Listing
December 2017

Raising Standards for the Evaluation of Future Psoriasis Therapeutics: A Critical Checklist.

Clin Pharmacol Ther 2017 Oct 24;102(4):642-648. Epub 2017 Aug 24.

Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.788DOI Listing
October 2017

Research Techniques Made Simple: Bioinformatics for Genome-Scale Biology.

J Invest Dermatol 2017 09;137(9):e163-e168

William Harvey Research Institute, Centre for Translational Bioinformatics, Barts and The London School of Medicine and Dentistry, Charterhouse Square, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2017.07.095DOI Listing
September 2017

Erratum to: Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study.

Am J Clin Dermatol 2017 08;18(4):591

Department of Dermatology, Icahn School of Medicine at Mount Sinai, 5 E 98th St, New York, NY, 10029, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40257-017-0295-8DOI Listing
August 2017

The potential utility of tildrakizumab: an interleukin-23 inhibitor for the treatment of psoriasis.

Expert Opin Investig Drugs 2017 Feb 1;26(2):243-249. Epub 2017 Jan 1.

a Dermatology Centre, Salford Royal NHS Foundation Trust , The University of Manchester, Manchester Academic Health Science Centre , Manchester , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2017.1274734DOI Listing
February 2017

Risk of Serious Infections in Patients with Psoriasis on Biologic Therapies: A Systematic Review and Meta-Analysis.

J Invest Dermatol 2016 08 13;136(8):1584-1591. Epub 2016 Apr 13.

Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2016.03.035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946794PMC
August 2016

Psoriasis - The Life Course Approach.

Acta Derm Venereol 2016 Aug;96(217):102-8

Department of Dermatology, University of Padua, IT-35122 Padua, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-2430DOI Listing
August 2016

Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.

Am J Clin Dermatol 2016 Jun;17(3):191-200

Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M6 8HD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40257-016-0179-3DOI Listing
June 2016

Erratum to: Letter from the Editors.

Dermatol Ther (Heidelb) 2016 Jun;6(2):303

Dermatological Sciences, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13555-016-0110-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906104PMC
June 2016

Erratum to: A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis.

Dermatol Ther (Heidelb) 2016 Jun;6(2):305

Division of Dermatology, Baylor University Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13555-016-0112-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906106PMC
June 2016

One SNP at a Time: Moving beyond GWAS in Psoriasis.

J Invest Dermatol 2016 Mar 22;136(3):567-573. Epub 2016 Jan 22.

The Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2015.11.025DOI Listing
March 2016

Erratum to: Letter from the Editors.

Dermatol Ther (Heidelb) 2016 Jun;6(2):303

Dermatological Sciences, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13555-016-0110-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906104PMC
June 2016

Safety of conventional systemic therapies for psoriasis on reproductive potential and outcomes.

J Dermatolog Treat 2015 30;26(4):329-34. Epub 2015 Jan 30.

The Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre , Manchester , UK and.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/09546634.2014.99
Publisher Site
http://dx.doi.org/10.3109/09546634.2014.991673DOI Listing
February 2016

Efficacy and safety of emerging immunotherapies in psoriasis.

Immunotherapy 2015 ;7(2):119-33

The Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/imt.14.101
Publisher Site
http://dx.doi.org/10.2217/imt.14.101DOI Listing
November 2015

Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

J Invest Dermatol 2015 Nov 8;135(11):2632-2640. Epub 2015 Jun 8.

Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2015.208DOI Listing
November 2015

Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritis.

Arthritis Rheumatol 2015 May;67(8):2011-9

Darren Plant, PhD, Anne Barton, MBChB, PhD, FRCP: Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester Academic Health Science Centre, Manchester, UK.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(
Web Search
http://doi.wiley.com/10.1002/art.39169
Publisher Site
http://dx.doi.org/10.1002/art.39169DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843946PMC
May 2015

Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.

Nat Commun 2015 Feb 5;6:6046. Epub 2015 Feb 5.

1] Arthritis Research UK Centre for Genetics and Genomics, The University of Manchester, Manchester M13 9PT, UK [2] NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester Foundation Trust and University of Manchester, Manchester Academy of Health Sciences, Manchester M13 9WU, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms7046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327416PMC
February 2015

Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis.

Lancet 2015 Feb;385 Suppl 1:S48

Centre for Musculoskeletal Research, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester Academy of Health Sciences, Manchester, UK.

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S014067361560363
Publisher Site
http://dx.doi.org/10.1016/S0140-6736(15)60363-4DOI Listing
February 2015

Pharmacogenomics and the resulting impact on psoriasis therapies.

Dermatol Clin 2015 Jan;33(1):149-60

The Dermatology Centre, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Salford, Manchester M6 8HD, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.det.2014.09.011DOI Listing
January 2015

Polymorphisms in IL-1B distinguish between psoriasis of early and late onset.

J Invest Dermatol 2014 May 12;134(5):1459-1462. Epub 2013 Nov 12.

The Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0022202X153676
Publisher Site
http://dx.doi.org/10.1038/jid.2013.485DOI Listing
May 2014

The spectrum of oculocutaneous disease: Part I. Infectious, inflammatory, and genetic causes of oculocutaneous disease.

J Am Acad Dermatol 2014 May;70(5):795.e1-25

Baylor University Medical Center, Dallas, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2013.12.013DOI Listing
May 2014

The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease.

J Am Acad Dermatol 2014 May;70(5):821.e1-19

Baylor University Medical Center, Dallas, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2013.12.019DOI Listing
May 2014

Unmasking of axial spondyloarthritis and oligoarthritis following discontinuation of tumour necrosis factor inhibitor therapy for psoriasis.

J Dermatolog Treat 2014 Feb 13;25(1):61-2. Epub 2012 Sep 13.

Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre , Manchester , UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/09546634.2012.713460DOI Listing
February 2014

The role of DMARDs in reducing the immunogenicity of TNF inhibitors in chronic inflammatory diseases.

Rheumatology (Oxford) 2014 Feb 14;53(2):213-22. Epub 2013 Aug 14.

Arthritis Research UK Epidemiology Unit, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester M13 9PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/ket260DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894670PMC
February 2014

Treating moderate to severe psoriasis - best use of biologics.

Expert Rev Clin Immunol 2014 Feb 27;10(2):269-79. Epub 2013 Dec 27.

Dermatology Department, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/1744666X.2014.873701DOI Listing
February 2014

Patients' narratives.

Curr Probl Dermatol 2013 24;44:145-57. Epub 2013 May 24.

Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000350194DOI Listing
January 2014

Expression of microRNA-184 in keratinocytes represses argonaute 2.

J Cell Physiol 2013 Dec;228(12):2314-23

School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.24401DOI Listing
December 2013

Dermatology: future therapeutic perspectives.

Dermatol Ther (Heidelb) 2013 Dec 3;3(2):115-6. Epub 2013 Dec 3.

The Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, M6 8HD, UK,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13555-013-0037-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889300PMC
December 2013

Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis.

J Invest Dermatol 2013 Oct 21;133(10):2340-2346. Epub 2013 Feb 21.

St John's Institute of Dermatology, Division of Medicine and Molecular Genetics, Guy's Hospital, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2013.149DOI Listing
October 2013

National and multinational guidelines in Europe: results from an online survey on awareness of different national and European psoriasis guidelines.

Arch Dermatol Res 2013 Sep 16;305(7):637-43. Epub 2013 Apr 16.

Division of Evidence-Based Medicine, Klinik für Dermatologie, Venerologie und Allergologie, Charité-Universitätsmedizin Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00403-013-1341-xDOI Listing
September 2013

Ustekinumab for psoriatic arthritis: close to the PSUMMIT?

Lancet 2013 Aug 13;382(9894):748-9. Epub 2013 Jun 13.

Dermatology Centre, Salford Royal National Health Service Foundation Trust, University of Manchester, Manchester M6 8HD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(13)60739-4DOI Listing
August 2013

Psoriasis and susceptibility to other autoimmune diseases: an outline for the clinician.

Expert Rev Clin Immunol 2013 Feb;9(2):99-101

Dermatology Centre, University of Manchester, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, M6 8HD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/eci.12.94DOI Listing
February 2013

Emerging therapies for the treatment of psoriasis.

Dermatol Ther (Heidelb) 2012 Dec 25;2(1):16. Epub 2012 Oct 25.

Baylor Research Institute, Baylor University Medical Center, 3900 Junius Street Suite 125, Dallas, TX 75246 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13555-012-0016-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510410PMC
December 2012

Ustekinumab for the treatment of psoriasis.

Expert Rev Clin Immunol 2011 Mar;7(2):155-64

Dermatological Sciences, Salford Royal Hospital, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M6 8HD, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/eci.11.4DOI Listing
March 2011

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.

Nat Genet 2010 Nov 17;42(11):985-90. Epub 2010 Oct 17.

Wellcome Trust Centre for Human Genetics, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.694DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749730PMC
November 2010

The use of ustekinumab in autoimmune disease.

Expert Opin Biol Ther 2010 Apr;10(4):587-604

Baylor Research Institute, Department of Dermatology, 3900 Junius Street, Suite 1125, Dallas, Texas 75204, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712591003724670DOI Listing
April 2010

The latest advances in pharmacogenetics and pharmacogenomics in the treatment of psoriasis.

Mol Diagn Ther 2010 Apr;14(2):81-93

Department of Dermatology, Baylor Research Institute, Dallas, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/bf03256357DOI Listing
April 2010

The future of biological therapies.

Semin Cutan Med Surg 2010 Mar;29(1):63-6

Dermatology Centre, Salford Royal Hospital, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://scmsjournal.com/article/buy_now/?id=220
Publisher Site
http://dx.doi.org/10.1016/j.sder.2010.02.004DOI Listing
March 2010

Genetic susceptibility to psoriasis: an emerging picture.

Genome Med 2009 Jul 22;1(7):72. Epub 2009 Jul 22.

ARC Epidemiology Unit, University of Manchester, Manchester, M13 9PT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/gm72DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717398PMC
July 2009

Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine.

Clin Dermatol 2008 Sep-Oct;26(5):438-47

Dermatologic Sciences, Hope Hospital, The University of Manchester, Manchester, M6 8HD UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clindermatol.2007.11.006DOI Listing
January 2009

Topical treatments for scalp psoriasis.

Drugs 2008 ;68(16):2293-302

Dermatological Sciences, Hope Hospital, The University of Manchester, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/0003495-200868160-00003DOI Listing
January 2009

Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis.

J Invest Dermatol 2008 Aug 7;128(8):1925-9. Epub 2008 Feb 7.

Dermatological Sciences, The University of Manchester, Salford Royal Hospital, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2008.16DOI Listing
August 2008

Medical dermatology.

Authors:
Richard B Warren

Clin Med (Lond) 2008 Apr;8(2):198-200

Dermatological Sciences, Salford Royal Hospital, The University of Manchester.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4953008PMC
http://dx.doi.org/10.7861/clinmedicine.8-2-198DOI Listing
April 2008

Precalcaneal congenital fibrolipomatous hamartoma.

Pediatr Dermatol 2007 Jan-Feb;24(1):74-5

Department of Dermatology, Royal Liverpool Children's Hospital, Liverpool, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1525-1470.2007.00340.xDOI Listing
May 2007